.jpg)
.png)
All
The NLA Recommendations for Patient-Centered Management of Dyslipidemia was recently published in the Journal of Clinical Lipidology.As you know, these Recommendations are a tool for clinicians who treat patients with dyslipidemia — and they should serve as guidance for treatment.... more
2026 #NLASessions Media Ambassador Program Program Overview The 2026 #NLASessions Media Ambassador Program empowers NLA's next generation of lipidologists — fellows-in-training, residents, associate members, and LSP recipients — to amplify NLA's mission, grow our digital presence, and bring... more
From University of Rochester Medica Center: University of Rochester Medical Center cardiologists are first in Upstate New York to offer a blood-cleansing therapy for people with extremely high cholesterol, including two-time heart attack survivor Bob Guesno, whose cholesterol level was nearly three... more
Esperion has announced that NEXLETOL™ (bempedoic acid) is now available in pharmacies in the United States. NEXLETOL is an oral, once-daily, tablet indicated as an adjunct to diet and maximally tolerated statin for the treatment of adults with heterozygous familial hypercholesterolemia (HeFH... more
The National Lipid Association is proud to host Industry Innovations, a podcast series dedicated to showcasing the latest advancements in lipidology. Designed for clinicians, this series offers exclusive insights into cutting-edge science, research breakthroughs, and emerging therapies... more
DS: Thank you for joining me today Fran. First, I would like to introduce myself and then you to the LipidSpin readers. I am Dan Soffer, a full-time internist, clinical lipidologist and educator at the University of Pennsylvania. I am also President-Elect of the Northeast Lipid Association (NELA)... more
The Fall Clinical Lipid Update has concluded and you can now access short summaries of select featured presentations. Click here for the NLA's meeting coverage from the CLU in Baltimore, MD. more
Candidate Listings Whether you are actively looking for a new job or simply keeping your options open, posting your CV / resumé on our Career Corner is an ideal way to reach employers in the field of lipidology. Members can post a candidate description on our... more
MIAMI, Fla. – (May 17, 2019) -- The National Lipid Association (NLA) today announced the release of an official scientific statement on Lipoprotein(a) [Lp(a)] clinical use at the NLA 2019 Scientific Sessions, May 16 – 19 at the Turnberry Isle Miami in Aventura, Florida. Created by an... more
Novartis received FDA approval for a label update that will allow for use of Leqvio ® (inclisiran) in certain patients at high risk of cardiovascular (CV) disease. This broader population allows for earlier Leqvio treatment in patients with elevated low-density lipoprotein cholesterol (LDL-C) and... more